Long-term Evaluation of a Mobile Application for Follow-up of Cardiac Patients (Cardio2U Study)

Antwerp University Hospital (UZA)

Status: Enrolling

Conditions: Mobile Health; Education; Follow-up

Treatments: Procedure: Cardio2U follow-up

Study type: Observational

Funder types: Other

Identifiers

NCT05951088

BUN B3002023000007

Details and patient eligibility

About

This trial has to aim to evaluate an innovative, in-house developed mobile application supporting patients in their home environment by actively involving them in different aspects of their condition and treatment. The usability, long-term adherence and patient satisfaction will be studied in patients with atrial fibrillation (AF) and/or heart failure (HF).

Full description

Atrial fibrillation (AF) and heart failure (HF) are global cardiovascular disease epidemics associated with significant morbidity and mortality. Their prevalence is already high and will continue to increase in the coming decades. A structured and efficient care system encompassing various aspects is needed to manage AF and HF morbidity and mortality. Technological developments and the increased use of smart devices, including in medical care, create opportunities to implement mobile applications to provide continuous, high-quality follow-up to patients. Our in-house developed application, recently improved and expended, provides a reliable source of educational material on AF and HF, with the ability to save health appointments, enter measurements (such as heart rate, blood pressure, weight) and keep a medication list (including notifications when medication should be taken). In addition, the application includes questionnaires to assess, for example, patients' knowledge, selfcare, quality of life, physical activity and symptoms. The application allows personalisation per patient depending on the clinical setting and indication. The innovative application will be evaluated in terms of usability, long-term adherence and patient satisfaction.

Enrollment: 200 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

1. Age ≥ 18 years,
2. Patients in whom AF or atrial flutter is diagnosed with an electrocardiogram (12-lead, Holter monitor,…) and/or patients in whom HF is diagnosed in their medical records,
3. Patients who are capable of signing the informed consent.

Exclusion criteria

1. Not able to speak and read Dutch,
2. Cognitive impaired (e.g. severe dementia),
3. No smartphone or tablet available.

Trial design

200 participants in 2 patient groups

atrial fibrillation patients

Description:

AF patients hospitalised at the cardiology department or coming for an outpatient visit

Treatment:

Procedure: Cardio2U follow-up

heart failure patients

Description:

HF patients hospitalised at the cardiology department or coming for an outpatient visit

Treatment:

Procedure: Cardio2U follow-up